Surgery for pancreatic cancer: Recent controversies and current practice

Gastroenterology

Volumn 128, Issue 6, 2005, Pages 1626-1641

  Wray, Curtis J ^a   Ahmad, Syed A ^a   Matthews, Jeffrey B ^a   Lowy, Andrew M ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CISPLATIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; MITOMYCIN C; OCTREOTIDE; PACLITAXEL; STREPTOZOCIN; TEGAFUR;

BILIARY TRACT DRAINAGE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPY; LYMPHADENECTOMY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS BIOPSY; PANCREAS CANCER; PANCREAS SURGERY; PANCREATICODUODENECTOMY; PERCUTANEOUS BIOPSY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SURGICAL MORTALITY; SURGICAL TECHNIQUE;

EID: 18844453135     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2005.03.035     Document Type: Article

References (105)

1. American Cancer Society Cancer facts and figures 2005 2005 American Cancer Society Atlanta, GA
2. S.S. Nitecki, M.G. Sarr, T.V. Colby, J.A. van Heerden Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221 1995 59 66
3. M. Trede, G. Schwall, H.D. Saeger Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality Ann Surg 211 1990 447 458
4. C.G. Willett, K. Lewandrowski, A.L. Warshaw Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy Ann Surg 217 1993 144 148
5. J. Klempnauer, G.J. Ridder, H. Bektas, R. Pichlmayr Surgery for exocrine pancreatic cancer--who are the 5- and 10-year survivors? Oncology 52 1995 353 359
6. S.L. Smith, P.S. Rajan Imaging of pancreatic adenocarcinoma with emphasis on multidetector CT Clin Radiol 59 2004 26 38
7. R.K. Zeman, C. Cooper, A.S. Zeiberg TNM staging of pancreatic carcinoma using helical CT AJR Am J Roentgenol 169 1997 459 464
8. G.M. Fuhrman, C. Charnsangavej, J.L. Abbruzzese Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms Am J Surg 167 1994 104 111
9. A.E. Hanbidge Cancer of the pancreas the best image for early detection--CT, MRI, PET or US? Can J Gastroenterol 16 2002 101 105
10. A. Zanello, R. Nicoletti, P. Brambilla Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions Radiol Med (Torino) 108 2004 194 207
11. J. Suits, R. Frazee, R.A. Erickson Endoscopic ultrasound and fine needle aspiration for the evaluation of pancreatic masses Arch Surg 134 1999 639 642
12. L. Palazzo, G. Roseau, B. Gayet Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan Endoscopy 25 1993 143 150
13. R.C. Frazee, H. Singh, R.A. Erickson Endoscopic ultrasound for peripancreatic masses Am J Surg 174 1997 596 598
14. K.J. Chang, C.G. Albers, R.A. Erickson Endoscopic ultrasound-guided fine needle aspiration of pancreatic carcinoma Am J Gastroenterol 89 1994 263 266
15. R.A. Erickson ERCP and pancreatic cancer Ann Surg Oncol 11 2004 555 557
16. A.L. Warshaw, J.E. Tepper, W.U. Shipley Laparoscopy in the staging and planning of therapy for pancreatic cancer Am J Surg 151 1986 76 80
17. A. Cuschieri, A.W. Hall, J. Clark Value of laparoscopy in the diagnosis and management of pancreatic carcinoma Gut 19 1978 672 677
18. B. Rumstadt, M. Schwab, K. Schuster The role of laparoscopy in the preoperative staging of pancreatic carcinoma J Gastrointest Surg 1 1997 245 250
19. T.G. John, J.D. Greig, D.C. Carter Carcinoma of the pancreatic head and periampullary region. Tumor staging with laparoscopy and laparoscopic ultrasonography Ann Surg 221 1995 156 164
20. K.C. Conlon, E. Dougherty, D.S. Klimstra The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy Ann Surg 223 1996 134 140
21. M.P. Callery, S.M. Strasberg, G.M. Doherty Staging laparoscopy with laparoscopic ultrasonography optimizing resectability in hepatobiliary and pancreatic malignancy J Am Coll Surg 185 1997 33 39
22. N.B. Merchant, K.C. Conlon Laparoscopic evaluation in pancreatic cancer Semin Surg Oncol 15 1998 155 165
23. P.P. Schachter, Y. Avni, M. Shimonov The impact of laparoscopy and laparoscopic ultrasonography on the management of pancreatic cancer Arch Surg 135 2000 1303 1307
24. 18Fluorodeoxyglucose- positron emission tomography in the management of patients with suspected pancreatic cancer Ann Surg 229 1999 729 737
25. P. Berberat, H. Friess, M. Kashiwagi Diagnosis and staging of pancreatic cancer by positron emission tomography World J Surg 23 1999 882 887
26. C. Kosugi, J. Furuse, H. Ishii Needle tract implantation of hepatocellular carcinoma and pancreatic carcinoma after ultrasound-guided percutaneous puncture clinical and pathologic characteristics and the treatment of needle tract implantation World J Surg 28 2004 29 32
27. C. Micames, P.S. Jowell, R. White Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA Gastrointest Endosc 58 2003 690 695
28. A.O. Whipple An evaluation of radical surgery for carcinoma of the pancreas and ampullary region Ann Intern Med 31 1949 624 627
29. D.S. Tyler, D.B. Evans Reoperative pancreaticoduodenectomy Ann Surg 219 1994 211 221
30. M.J. Heslin, L.E. Harrison, A.D. Brooks Is intra-abdominal drainage necessary after pancreaticoduodenectomy? J Gastrointest Surg 2 1998 373 378
31. K.C. Conlon, D. Labow, D. Leung Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection Ann Surg 234 2001 487 493
32. S.P. Povoski, M.S. Karpeh Jr, K.C. Conlon Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy Ann Surg 230 1999 131 142
33. T.A. Sohn, C.J. Yeo, J.L. Cameron Do preoperative biliary stents increase postpancreaticoduodenectomy complications? J Gastrointest Surg 4 2000 258 267
34. P.W. Pisters, W.A. Hudec, K.R. Hess Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients Ann Surg 234 2001 47 55
35. D.A. McClusky 3rd, L.J. Skandalakis, G.L. Colborn Harbinger or hermit? Pancreatic anatomy and surgery through the ages - part 3 World J Surg 26 2002 1512 1524
36. L.W. Traverso, W.P. Longmire Jr Preservation of the pylorus in pancreaticoduodenectomy Surg Gynecol Obstet 146 1978 959 962
37. L.W. Traverso, W.P. Longmire Jr Preservation of the pylorus in pancreaticoduodenectomy a follow-up evaluation Ann Surg 192 1980 306 310
38. P.W. Lin, Y.J. Lin Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy Br J Surg 86 1999 603 607
39. C.A. Seiler, M. Wagner, C. Sadowski Randomized prospective trial of pylorus-preserving vs. classic duodenopancreatectomy (Whipple procedure) initial clinical results J Gastrointest Surg 4 2000 443 452
40. A. Zerbi, G. Balzano, R. Patuzzo Comparison between pylorus-preserving and Whipple pancreaticoduodenectomy Br J Surg 82 1995 975 979
41. K.T. Tran, H.G. Smeenk, C.H. van Eijck Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors Ann Surg 240 2004 738 745
42. S. Pedrazzoli, V. DiCarlo, R. Dionigi Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group Ann Surg 228 1998 508 517
43. C.J. Yeo, J.L. Cameron, T.A. Sohn Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma comparison of morbidity and mortality and short-term outcome Ann Surg 229 1999 613 622
44. C.J. Yeo, J.L. Cameron, K.D. Lillemoe Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2 randomized controlled trial evaluating survival, morbidity, and mortality Ann Surg 236 2002 355 366
45. J.G. Fortner, D.K. Kim, A. Cubilla Regional pancreatectomy en bloc pancreatic, portal vein and lymph node resection Ann Surg 186 1977 42 50
46. G.M. Fuhrman, S.D. Leach, C.A. Staley Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group Ann Surg 223 1996 154 162
47. S.D. Leach, J.E. Lee, C. Charnsangavej Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head Br J Surg 85 1998 611 617
48. J.D. Roder, H.J. Stein, J.R. Siewert Carcinoma of the periampullary region who benefits from portal vein resection? Am J Surg 171 1996 170 174
49. L.E. Harrison, D.S. Klimstra, M.F. Brennan Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection? Ann Surg 224 1996 342 347
50. D.W. Crist, J.V. Sitzmann, J.L. Cameron Improved hospital morbidity, mortality, and survival after the Whipple procedure Ann Surg 206 1987 358 365
51. I. Kurosaki, K. Hatakeyama Omental wrapping of skeletonized major vessels after pancreaticoduodenectomy Int Surg 89 2004 90 94
52. M.A. Muftuoglu, A. Saglam A novel reconstructive procedure after pancreaticoduodenectomy J-pouch dunking pancreaticojejunostomy Hepatogastroenterology 50 2003 2233 2235
53. S. Ohwada, Y. Tanahashi, T. Ogawa In situ vs ex situ pancreatic duct stents of duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy with Billroth I-type reconstruction Arch Surg 137 2002 1289 1293
54. K.D. Lillemoe, J.L. Cameron, M.P. Kim Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial J Gastrointest Surg 8 2004 766 774
55. M. Buchler, H. Friess, I. Klempa Role of octreotide in the prevention of postoperative complications following pancreatic resection Am J Surg 163 1992 125 130
56. H. Friess, H.G. Beger, U. Sulkowski Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis Br J Surg 82 1995 1270 1273
57. M. Montorsi, M. Zago, F. Mosca Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections a prospective, controlled, randomized clinical trial Surgery 117 1995 26 31
58. C. Bassi, M. Falconi, D. Lombardi Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Italy. Italian Study Group Digestion 55 Suppl 1 1994 41 47
59. M.E. Presti, F.R. Burton, M.L. Niehoff Effect of octreotide on stimulated insulin release from pancreatic tissue slices Pancreas 16 1998 141 147
60. A.M. Lowy, J.E. Lee, P.W. Pisters Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease Ann Surg 226 1997 632 641
61. C.J. Yeo, J.L. Cameron, K.D. Lillemoe Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial Ann Surg 232 2000 419 429
62. C.J. Yeo Does prophylactic octreotide benefit patients undergoing elective pancreatic resection? J Gastrointest Surg 3 1999 223 224
63. M.G. Sarr The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy a prospective, multicenter, double-blinded, randomized, placebo-controlled trial J Am Coll Surg 196 2003 556 564
64. B. Suc, S. Msika, M. Piccinini Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection a prospective, multicenter randomized controlled trial Arch Surg 139 2004 288 294
65. J.D. Birkmeyer, A.L. Warshaw, S.R. Finlayson Relationship between hospital volume and late survival after pancreaticoduodenectomy Surgery 126 1999 178 183
66. T.A. Gordon, H.M. Bowman, J.M. Tielsch Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality Ann Surg 228 1998 71 78
67. V. Ho, M.J. Heslin Effect of hospital volume and experience on in-hospital mortality for pancreaticoduodenectomy Ann Surg 237 2003 509 514
68. M.D. Lieberman, H. Kilburn, M. Lindsey Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy Ann Surg 222 1995 638 645
69. J.A. Sosa, H.M. Bowman, T.A. Gordon Importance of hospital volume in the overall management of pancreatic cancer Ann Surg 228 1998 429 438
70. D.J. Gouma, R.C. van Geenen, T.M. van Gulik Rates of complications and death after pancreaticoduodenectomy risk factors and the impact of hospital volume Ann Surg 232 2000 786 795
71. A.S. Rosemurgy, M. Bloomston, F.M. Serafini Frequency with which surgeons undertake pancreaticoduodenectomy determines length of stay, hospital charges, and in-hospital mortality J Gastrointest Surg 5 2001 21 26
72. R.H. Andtbacka, D.B. Evans, P.W. Pisters Surgical and endoscopic palliation for pancreatic cancer Minerva Chir 59 2004 123 136
73. D.J. Deziel, B. Wilhelmi, E.D. Staren Surgical palliation for ductal adenocarcinoma of the pancreas Am Surg 62 1996 582 588
74. K.D. Lillemoe, J.L. Cameron, J.M. Hardacre Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial Ann Surg 230 1999 322 328
75. M.H. Kalser, S.S. Ellenberg Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120 1985 899 903
76. C.J. Yeo, J.L. Cameron, M.M. Maher A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy Ann Surg 222 1995 580 588
77. C.G. Moertel, L.L. Gunderson, J.A. Mailliard Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group J Clin Oncol 12 1994 21 27
78. C.J. Yeo, R.A. Abrams, L.B. Grochow Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience Ann Surg 225 1997 621 633
79. J.H. Klinkenbijl, J. Jeekel, T. Sahmoud Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region phase III trial of the EORTC gastrointestinal tract cancer cooperative group Ann Surg 230 1999 776 782
80. J.P. Neoptolemos, J.A. Dunn, D.D. Stocken Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer a randomised controlled trial Lancet 358 2001 1576 1585
81. J.P. Neoptolemos, D.D. Stocken, H. Friess A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 2004 1200 1210
82. V.J. Picozzi, R.A. Kozarek, L.W. Traverso Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma Am J Surg 185 2003 476 480
83. R.A. Wolff, D.B. Evans, D.M. Gravel Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma Clin Cancer Res 7 2001 2246 2253
84. S.N. Hochwald, E.C. Burke, W.R. Jarnagin Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma Arch Surg 134 1999 261 266
85. M.J. Heslin, A.D. Brooks, S.N. Hochwald A preoperative biliary stent is associated with increased complications after pancreatoduodenectomy Arch Surg 133 1998 149 154
86. P. Hodul, S. Creech, J. Pickleman The effect of preoperative biliary stenting on postoperative complications after pancreaticoduodenectomy Am J Surg 186 2003 420 425
87. L. Capussotti, P. Massucco, D. Ribero Extended lymphadenectomy and vein resection for pancreatic head cancer outcomes and implications for therapy Arch Surg 138 2003 1316 1322
88. P. Bachellier, H. Nakano, P.D. Oussoultzoglou Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile? Am J Surg 182 2001 120 129
89. T. Nakagohri, T. Kinoshita, M. Konishi Survival benefits of portal vein resection for pancreatic cancer Am J Surg 186 2003 149 153
90. T.J. Howard, N. Villanustre, S.A. Moore Efficacy of venous reconstruction in patients with adenocarcinoma of the pancreatic head J Gastrointest Surg 7 2003 1089 1095
91. H. Nakano, P. Bachellier, J.C. Weber Arterial and vena caval resections combined with pancreaticoduodenectomy in highly selected patients with periampullary malignancies Hepatogastroenterology 49 2002 258 262
92. J.F. Tseng, C.P. Raut, J.E. Lee Pancreaticoduodenectomy with vascular resection margin status and survival duration J Gastrointest Surg 8 2004 935 950
93. K.E. Bakkevold, B. Arnesjo, B. Kambestad Carcinoma of the pancreas and papilla of Vater--assessment of resectability and factors influencing resectability in stage I carcinomas. A prospective multicentre trial in 472 patients Eur J Surg Oncol 18 1992 494 507
94. F.A. Calvo, R. Matute, J.L. Garcia-Sabrido Neoadjuvant chemoradiation with tegafur in cancer of the pancreas initial analysis of clinical tolerance and outcome Am J Clin Oncol 27 2004 343 349
95. A.R. Sasson, R.W. Wetherington, J.P. Hoffman Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas analysis of histopathology and outcome Int J Gastrointest Cancer 34 2003 121 128
96. A.M. Cooperman, H. Snady, H.W. Bruckner Long-term follow-up of twenty patients with adenocarcinoma of the pancreas resection following combined modality therapy Surg Clin North Am 81 2001 699 708
97. R.R. White, H.I. Hurwitz, M.A. Morse Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas Ann Surg Oncol 8 2001 758 765
98. T.M. Breslin, K.R. Hess, D.B. Harbison Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas treatment variables and survival duration Ann Surg Oncol 8 2001 123 132
99. V.K. Mehta, G. Fisher, J.A. Ford Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas J Gastrointest Surg 5 2001 27 35
100. H. Snady, H. Bruckner, A. Cooperman Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial Cancer 89 2000 314 327
101. J.P. Hoffman, J.L. Weese, L.J. Solin A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas Am J Surg 169 1995 71 77
102. D.B. Evans, T.A. Rich, D.R. Byrd Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas Arch Surg 127 1992 1335 1339
103. T.A. Sohn, C.J. Yeo, J.L. Cameron, L. Koniaris, S. Kaushal, R.A. Abrams, P.K. Sauter, J. Coleman, R.H. Hruban, K.D. Lillemoe Resected adenocarcinoma of the pancreas--616 patients results, outcomes, and prognostic indicators J Gastrointest Surg 4 2000 567 579
104. Y. Nishimura, R. Hosotani, Y. Shibamoto, M. Kokubo, S. Kanamori, K. Sasai, M. Hiraoka, G. Ohshio, M. Imamura, M. Takahashi, M. Abe External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer analysis of survival rates and complications Int J Radiat Oncol Biol Phys 39 1997 39 49
105. C.J. Yeo, J.L. Cameron, K.D. Lillemoe, J.V. Sitzmann, R.H. Hruban, S.N. Goodman, W.C. Dooley, J. Coleman, H.A. Pitt Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients Ann Surg 221 1995 721 731